Quality Control Associate Scientist
                  Zoetis, Inc | |
                                     United States, Iowa, Charles City    | |
                                   Nov 03, 2025    | |
|                                             
 Position Summary: The Quality Control Associate Scientist will serve as the primary coordinator for the inventory management and requalification of critical ELISA reagents within the Quality Control (QC) department. The main responsibility is to ensure the integrity and availability of ELISA critical reagents by leading equivalency studies and authoring comprehensive reports for USDA submission. This role also supports ELISA reference requalification and will coordinate new reference qualification testing with cross-functional groups. In addition to ELISA reagent management, this team contributor role supports QC compliance by reviewing executed bench records, ensuring scheduling adherence, performing periodic Standard Operating Procedures (SOP) reviews to ensure alignment with regulatory guidelines, and assist with team action items and laboratory investigation reports. The colleague will be trained to perform testing and is expected to maintain in-depth knowledge of assay performance. The successful candidate will assist Team Leader in directing and prioritizing tasks to ensure accurate, timely completion of tests and records, supporting reliable results and timely product delivery. Position Responsibilities 
 Education and Experience 
 Technical Skills 
 
 Physical Position Requirements 
 Any unsolicited resumes sent to Zoetis from a third party, such as an Agency recruiter, including unsolicited resumes sent to a Zoetis mailing address, fax machine or email address, directly to Zoetis employees, or to Zoetis resume database will be considered Zoetis property. Zoetis will NOT pay a fee for any placement resulting from the receipt of an unsolicited resume. Zoetis will consider any candidate for whom an Agency has submitted an unsolicited resume to have been referred by the Agency free of any charges or fees. This includes any Agency that is an approved/engaged vendor but does not have the appropriate approvals to be engaged on a search. Zoetis is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status or any other protected classification. Disabled individuals are given an equal opportunity to use our online application system. We offer reasonable accommodations as an alternative if requested by an individual with a disability. Please contact Zoetis Colleague Services at zoetiscolleagueservices@zoetis.com to request an accommodation. Zoetis also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must possess or obtain authorization to work in the US for Zoetis. Zoetis retains sole and exclusive discretion to pursue sponsorship for the acquisition or maintenance of nonimmigrant status and employment eligibility, considering factors such as availability of qualified US workers. Individuals requiring sponsorship must disclose this fact. Please note that Zoetis seeks information related to job applications from candidates for jobs in the U.S. solely via the following: (1) our company website at www.Zoetis.com/careers site, or (2) via email to/from addresses using only the Zoetis domain of "@zoetis.com". In addition, Zoetis does not use Google Hangout for any recruitment related activities. Any solicitation or request for information related to job applications with Zoetis via any other means and/or utilizing email addresses with any other domain should be disregarded. In addition, Zoetis will never ask candidates to make any type of personal financial investment related to gaining employment with Zoetis. | |
                            
  
 
                 
                                    
                                  Nov 03, 2025